Advertisements


We are Sorry, This Page doesn't Exist


Vetr Crowd Downgrades Twilio

The .....»»

Category: blogSource: benzingaApr 18th, 2018

Vetr Crowd Downgrades AT&T

The Vetr community on Monday downgraded shares of AT&T I.....»»

Category: blogSource: benzingaApr 17th, 2018

Vetr Crowd Downgrades Mazor Robotics But Remains Bullish

The Vetr community on Thursday d.....»»

Category: blogSource: benzingaApr 13th, 2018

Vetr Crowd Downgrades T-Mobile

The Vetr com.....»»

Category: blogSource: benzingaApr 11th, 2018

Vetr Crowd Downgrades Cisco

The Vetr community on Thursday downgraded Cisco Systems, Inc. (.....»»

Category: blogSource: benzingaApr 6th, 2018

Analysts See Limited Upside For Visteon

Visteon Corp (NASDAQ: VC) was hit with two downgrades recently as sell-side analysts project limited upside for the auto supplier stock.  Latest Ratings for VC DateF.....»»

Category: blogSource: benzingaJul 21st, 2018

Goldman downgrades Clorox to Sell on "unsustainably high relative valuation"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 18th, 2018

B. Riley FBR downgrades Oramed to Neutral with $5 target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 16th, 2018

Morgan Stanley Downgrades Acceleron As Valuation Reaches Price Target

Acceleron Pharma Inc (NASDAQ: XLRN) shares have gained about 39 percent since June 28 in reaction to positive Phase 3 study results for its luspatercept in lo Latest Ratings for XLRN DateFirm.....»»

Category: blogSource: benzingaJul 13th, 2018

Morgan Stanley Downgrades Jazz Pharmaceuticals As Stock Approaches Price Target

Morgan Stanley analyst wants to move to the sidelines on Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) as the stock has gained around 34 percent year-to-date and approached his price target of $183. Late.....»»

Category: blogSource: benzingaJul 11th, 2018

Target Has a New Line of Low-Calorie, High-Protein Ice Cream

The new Archer Farm's ice cream will sell for $4 a pint. Target now has its own line of low-calorie ice creams. Si.....»»

Category: europeSource: fortuneJul 10th, 2018

Bloom Energy boosts IPO target to $310.5M

Bloom Energy Corp. on Monday set the price range for an IPO planned later this month in which it hopes to raise up to $310.5 million. The Sunnyvale-based fuel cell business hopes to sell 18 million shares for between $13 and $15 each, which would .....»»

Category: topSource: bizjournalsJul 9th, 2018

"It"s Time To Get Defensive": Morgan Stanley Downgrades Tech Stocks To Sell

Last weekend, when discussing why the trade war with China has now lapsed into what it called a "vicious cycle" that can only end with a market drop, Morgan Stanley wrote that it expects further fallout from trade wars.....»»

Category: blogSource: zerohedgeJul 8th, 2018

Nielsen downgraded to Sell with $28 price target at Goldman Sachs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 2nd, 2018

Benzinga"s Top Upgrades, Downgrades For June 28, 2018

Top Upgrades Analysts at Benchmark upgraded Progress Software Corporation (NASDAQ: PRGS) from Sell to Hold. Progress Software shares rose 4.91 percent to $36.51 in pre-market trading. read more.....»»

Category: blogSource: benzingaJun 28th, 2018

Musk Says Goldman "In For A Rude Awakening" After Bearish Report

Overnight, Goldman analyst David Tamberrino - who has a Sell rating on Tesla and a $195 price target - published a note that will guarantee he won't .....»»

Category: blogSource: zerohedgeJun 27th, 2018

Kezar Life Sciences stock jumps 18% after IPO raises $75M

Shares of Kezar Life Sciences Inc. jumped 18 percent on Thursday after it raised $75 million in an upsized IPO that hit the middle of its price target range. The South San Francisco biotech sold 5 million shares at $15. It was expected to sell 4.7 .....»»

Category: topSource: bizjournalsJun 21st, 2018

Wells Fargo Downgrades Syntel After 48% Run, Sees Need For Client Diversification

Syntel, Inc. (NASDAQ: SYNT) shares have run up in the year-to-date period, prompting an analyst at Wells Fargo Securities to press the sell button. Latest Ratings for SYNT DateFirmActionFromTo.....»»

Category: blogSource: benzingaJun 21st, 2018

Sirius XM stock falls after Goldman downgrades to sell

Sirius XM Holdings Inc. shares are down 4.1% in Thursday trading after Goldman Sachs analyst Brett Feldman downgraded the stock to sell from neutral. "We believe the stock's material YTD outperformance (+40% vs. +4% for the.....»»

Category: topSource: marketwatchJun 21st, 2018

Kezar Life Sciences raises $75M in slightly upsized IPO

Kezar Life Sciences Inc. raised $75 million Thursday in an upsized IPO that hit the middle of its price target range. The South San Francisco biotech sold 5 million shares at $15. It was expected to sell 4.7 million shares for between $14 and $16. Insi.....»»

Category: topSource: bizjournalsJun 21st, 2018